zabilugene almadenorepvec

Advertisement

cGxPJobs Banner

Theriva Biologics Advances VCN-01 in Pancreatic Cancer

ROCKVILLE, Md., August 6, 2026 Theriva Biologics announced that the first patient has been dosed in the VIRAGE2 Phase...

By cGxPwire Editor
August 7, 2026

Read More

Advertisement

cGxPJobs

Directory